National and Kapodistrian University of Athens
Μελέτη και αξιολόγηση αιτιολογικών παραγόντων, μεθόδων και βιοδεικτών σε ασθενείς με χρόνια θρομβοεμβολική πνευμονική υπέρταση που υποβάλλονται σε αγγειοπλαστική των πνευμονικών αγγείων
Abstract
dc:descriptionChronic Thromboembolic Pulmonary hypertension (CTEPH) is a life threatening complication of pulmonary embolism and a major cause of chronic PH leading to right heart failure and death. Autoimmune, inflammatory and thrombophilia factors are involved in the pathophysiology of the CTEPH disease while the risk factors for Thromboembolic Disease seem to play a central but not entirely clarified role. CTEPH can be a curable disease. Pulmonary endarterectomy and lifelong anticoagulation are the treatment of choice. For technically inoperable cases that represent 30% of all cases, Balloon Pulmonary Angioplasty and lifelong anticoagulation should be considered as it represents a new therapeutic option for patients with CTEPH or resistant/relapsed PE after endarterectomy. In this case the patients benefit from a considerable improvement of pulmonary dynamics, right heart function and overall survival. The study of thrombophilia related factors such as natural coagulation inhibitors, APCR, point mutations in the genes encoding for FV, FII, MTHFR, PAI-1 as well as the fibrinolysis mechanism, will provide new highlights in the pathogenesis of the CTEPH and its correlation to Chronic Thromboembolic Disease. Furthermore, in the present study we will investigate for novel biomarkers that could comprise prognostic indicators of the effectiveness of the therapeutic scheme as well as possible disease recurrence and overall patient outcome.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kostelidou, Theodora
- Κωστελίδου, Θεοδώρα
Subjects
dc:subject × 14- ΧΘΠΥ — Χρόνια Θρομβοεμβολική Πνευμονική Υπέρταση
- ΑΠΑΜ — αγγειοπλαστική πνευμονικών αγγείων με μπαλόνι
- TAFI — αναστολέας ινωδόλυσης ενεργοποιούμενος από θρομβίνη
- TFPI —αναστολέας της οδού του ιστικού παράγοντα (tissue factor pathway inhibitor)
- CTEPH(Chronic Thromboembolic Pulmonary Hypertension)
- BPA (Balloon Pulmonary Angioplasty)
- TAFI/CPB2 (thrombin- activatable fibrinolysis inhibitor)
- TFPI (tissue factor pathway inhibitor)
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62571